DGX
Quest Diagnostics Incorporated
Stock
$233.33+2.24 (+0.97%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $88M
- YoY, 2025
- 0.0%
- 5-year CAGR
- −1.9%
- 10-year CAGR
- +5.4%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $88M | 0.0% |
| 2024 | $88M | +14.3% |
| 2023 | $77M | 0.0% |
| 2022 | $77M | −2.5% |
| 2021 | $79M | −18.6% |
| 2020 | $97M | +73.2% |
| 2019 | $56M | −8.2% |
| 2018 | $61M | −22.8% |
| 2017 | $79M | +14.5% |
| 2016 | $69M | +32.7% |
| 2015 | $52M | +2.0% |
| 2014 | $51M | +82.1% |
| 2013 | $28M | −44.0% |
| 2012 | $50M | −30.6% |
| 2011 | $72M | +33.5% |
| 2010 | $54M | −28.2% |
| 2009 | $75M | +6.3% |
| 2008 | $71M | +24.1% |
| 2007 | $57M | — |